The Cooper Companies, Inc. logo
The Cooper Companies, Inc. (COO)
Compare

The Cooper Companies, Inc. (COO) Earnings Per Share (EPS): 1.18

popular:market cap|pe ratio|revenue|price history|total return

Is The Cooper Companies, Inc.’s earnings per share (EPS) high or low?

The Cooper Companies, Inc.'s earnings per share (EPS) of 1.18 is 90% below its 5-year average of 11.98, near the low end of its 5-year range (1.18–59.73).

As of Sunday, June 14, 2026. 38.70% below its 12-month average of 1.92.

P/E Ratio|EPS CAGR|Net Income|Earnings Yield|All Metrics

COO Earnings Per Share (EPS) Chart

COO Earnings Per Share (EPS)
1.88-4.57% 1Y
Zoom

COO Average Earnings Per Share (EPS) Chart

COO Current vs Average Earnings Per Share (EPS) Chart

COO Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

1.18

EARNINGS PER SHARE (EPS) AVG TTM

1.92

EARNINGS PER SHARE (EPS) AVG 3Y

1.82

EARNINGS PER SHARE (EPS) AVG 5Y

11.98

EARNINGS PER SHARE (EPS) AVG 10Y

9.24

EARNINGS PER SHARE (EPS) AVG 15Y

7.80

EARNINGS PER SHARE (EPS) AVG 20Y

6.28

CURRENT VS TTM AVG

-38.70%

CURRENT VS 3Y AVG

-35.34%

CURRENT VS 5Y AVG

-90.15%

CURRENT VS 10Y AVG

-87.24%

CURRENT VS 15Y AVG

-84.87%

CURRENT VS 20Y AVG

-81.20%

COO Competitors' Earnings Per Share (EPS)

NAMEMARKET CAPEARNINGS PER SHARE (EPS)TTM3Y5Y
The Cooper Companies, Inc. (COO)$13.24B1.181.921.8211.98
Solventum Corporation (SOLV)$13.66B8.175.856.827.06
Align Technology, Inc. (ALGN)$12.52B5.965.645.439.01
Baxter International Inc. (BAX)$10.77B-2.10-1.51-0.650.36
Walgreens Boots Alliance, Inc. (WBA)$10.37B-7.29-6.79-1.56-0.26
Hologic, Inc. (HOLX)$16.97B2.402.923.224.07
Charles River Laboratories International, Inc. (CRL)$9.03B-3.76-1.354.035.21
Tempus AI, Inc. (TEM)$8.35B-1.72-3.00-2.43-2.16
Bio-Rad Laboratories, Inc. (BIO)$7.73B6.07-18.74-45.2814.90
Moderna, Inc. (MRNA)$19.80B-8.15-8.27-1.903.46

EPS Comparison

Trailing EPS (TTM)

$1.18

Forward EPS (Est.)

$4.63

P/E Ratio

57.5

Formula: EPS = Net Income / Weighted Average Shares Outstanding

Why EPS matters:

  • Directly impacts stock valuation through P/E ratio
  • Used to calculate dividend coverage and payout ratios
  • Enables comparison across companies of different sizes
  • Growth in EPS often correlates with stock price appreciation

The Cooper Companies, Inc. Earnings Per Share (EPS) Formula & Definition

EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

The Cooper Companies, Inc. Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for The Cooper Companies, Inc. (COO)?
The earnings per share (EPS) for COO stock is 1.18.
Is The Cooper Companies, Inc.'s earnings per share (EPS) high or low?
The Cooper Companies, Inc.'s earnings per share (EPS) of 1.18 is 90% below its 5-year average of 11.98, near the low end of its 5-year range (1.18–59.73).
What is the TTM average earnings per share (EPS) for The Cooper Companies, Inc. (COO)?
The TTM average earnings per share (EPS) for COO stock is 1.92.
What is the 3Y average earnings per share (EPS) for The Cooper Companies, Inc. (COO)?
The 3Y average earnings per share (EPS) for COO stock is 1.82.
What is the 5Y average earnings per share (EPS) for The Cooper Companies, Inc. (COO)?
The 5Y average earnings per share (EPS) for COO stock is 11.98.
What is the 10Y average earnings per share (EPS) for The Cooper Companies, Inc. (COO)?
The 10Y average earnings per share (EPS) for COO stock is 9.24.
What is the 15Y average earnings per share (EPS) for The Cooper Companies, Inc. (COO)?
The 15Y average earnings per share (EPS) for COO stock is 7.80.
What is the 20Y average earnings per share (EPS) for The Cooper Companies, Inc. (COO)?
The 20Y average earnings per share (EPS) for COO stock is 6.28.

The Cooper Companies, Inc. Earnings Per Share (EPS) History

DATEEARNINGS PER SHARE (EPS)
2025-10-311.88
2024-10-311.97
2023-10-311.49
2022-10-311.96
2021-10-3159.73
2020-10-314.86
2019-10-319.47
2018-10-312.85
2017-10-317.63
2016-10-315.65
2015-10-314.20
2014-10-315.61
2013-10-316.09
2012-10-315.18
2011-10-313.74
2010-10-312.48
2009-10-312.23
2008-10-311.46
2007-10-31-0.25
2006-10-311.49
2005-10-312.06
2004-10-312.83
2003-10-312.20
2002-10-311.60
2001-10-311.25
2000-10-311.02
1999-10-310.89
1998-10-311.35
1997-10-311.20
1996-10-310.72

Related Metrics

P/E RatioEPS CAGRNet IncomeEarnings YieldAll Metrics

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

San Ramon, CA
16,000 employees
www.coopercos.com
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert G. White
View full financials